Healthy Cash Flow:
Company disclosures indicate revenue surpassed $500M for FY2023 and operations have been free cash flow positive since early 2023, signaling solid liquidity and operating discipline.
Product Line Growth:
Expansion beyond core payroll is evident through strong growth in 401(k) and spending‑account lines and the acquisition of Guideline to deepen retirement offerings.
Investor Backing & Capital Strength:
A mid‑2025 secondary tender exceeding $200M at roughly a $9.3B valuation underscores continuing late‑stage investor confidence and access to capital.
